Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 20900

1.

Errata.

[No authors listed]

Anticancer Res. 2019 Jan;39(1):527. No abstract available.

PMID:
30591506
2.

Errata.

[No authors listed]

Anticancer Res. 2019 Jan;39(1):527. No abstract available.

PMID:
30591505
3.

Metabolomics-based Discovery of Serum Biomarkers to Predict the Side-effects of Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.

Nishiumi S, Fujigaki S, Kobayashi T, Kojima T, Ito Y, Daiko H, Kato K, Shoji H, Kodama Y, Honda K, Yoshida M.

Anticancer Res. 2019 Jan;39(1):519-526. doi: 10.21873/anticanres.13143.

PMID:
30591504
5.

Essentiality of Imaging Diagnostic Criteria Specific to Rectal Neuroendocrine Tumors for Detecting Metastatic Lymph Nodes.

Kudou M, Arita T, Nakanishi M, Kuriu Y, Murayama Y, Shoda K, Kosuga T, Konishi H, Morimura R, Shiozaki A, Ikoma H, Kubota T, Fujiwara H, Okamoto K, Otsuji E.

Anticancer Res. 2019 Jan;39(1):505-510. doi: 10.21873/anticanres.13141.

PMID:
30591502
6.

Predictive Factors of Pancreatic Fistula After Pancreaticoduodenectomy and External Validation of Predictive Scores.

DI Martino M, Mora-Guzman I, Blanco-Traba YG, Díaz MC, Khurram MA, Martín-Pérez E.

Anticancer Res. 2019 Jan;39(1):499-504. doi: 10.21873/anticanres.13140.

PMID:
30591501
7.

Predictors of Acute Radiation Esophagitis in Non-small Cell Lung Cancer Patients Treated With Accelerated Hyperfractionated Chemoradiotherapy.

Wada K, Kishi N, Kanayama N, Hirata T, Ueda Y, Kawaguchi Y, Morimoto M, Konishi K, Imamura F, Ogawa K, Teshima T.

Anticancer Res. 2019 Jan;39(1):491-497. doi: 10.21873/anticanres.13139.

PMID:
30591500
8.

An Unusual Case of Cecal Mesenteric Dedifferentiated Liposarcoma Involving the Ileocolic Artery Resected by Right Hemicolectomy.

Zhang D, Williams WD, Lai J.

Anticancer Res. 2019 Jan;39(1):487-490. doi: 10.21873/anticanres.13138.

PMID:
30591499
9.

Health-related Quality of Life and Toxicity After Single-fraction High-dose-rate Brachytherapy With External Beam Radiotherapy for Localized and Locally Advanced Prostate Cancer.

Makino T, Nakashima K, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Kumano T, Mizokami A.

Anticancer Res. 2019 Jan;39(1):477-486. doi: 10.21873/anticanres.13137.

PMID:
30591498
10.

Influence of Neoadjuvant Chemotherapy on Short-term Outcomes After Minimally Invasive Esophagectomy for Esophageal Cancer.

Nomoto D, Yoshida N, Akiyama T, Kiyozumi Y, Eto K, Hiyoshi Y, Nagai Y, Iwatsuki M, Iwagami S, Baba Y, Miyamoto Y, Baba H.

Anticancer Res. 2019 Jan;39(1):471-475. doi: 10.21873/anticanres.13136.

PMID:
30591497
11.

Scheduled Intravenous Acetaminophen for Postoperative Management of Patients Who Had Thoracoscopic Esophagectomy for Esophageal Cancer.

Kitagawa H, Namikawa T, Iwabu J, Uemura S, Munekage M, Tsuda S, Yokota K, Kobayashi M, Hanazaki K.

Anticancer Res. 2019 Jan;39(1):467-470. doi: 10.21873/anticanres.13135.

PMID:
30591496
12.

No Ink on Ductal Carcinoma In Situ: A Single Centre Experience.

Fregatti P, Gipponi M, Depaoli F, Murelli F, Guenzi M, Bonzano E, Ceppi M, Friedman D.

Anticancer Res. 2019 Jan;39(1):459-466. doi: 10.21873/anticanres.13134.

PMID:
30591495
13.

Prognostic Significance of Sarcopenia and Systemic Inflammatory Response in Patients With Esophageal Cancer.

Matsunaga T, Miyata H, Sugimura K, Motoori M, Asukai K, Yanagimoto Y, Takahashi Y, Tomokuni A, Yamamoto K, Akita H, Nishimura J, Wada H, Takahashi H, Yasui M, Omori T, Oue M, Yano M.

Anticancer Res. 2019 Jan;39(1):449-458. doi: 10.21873/anticanres.13133.

PMID:
30591494
14.

PD-1 Expression on Circulating CD8+ T-Cells as a Prognostic Marker for Patients With Gastric Cancer.

Saito H, Shimizu S, Kono Y, Murakami Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Ashida K, Fujiwara Y.

Anticancer Res. 2019 Jan;39(1):443-448. doi: 10.21873/anticanres.13132.

PMID:
30591493
15.

Polypoid Undifferentiated Carcinoma With Osteoclast-like Giant Cells Arising in the Distal Common Bile Duct: A Rare Case Report.

Liao X, Houldsworth J, Luo J, Harpaz N, Zhu H.

Anticancer Res. 2019 Jan;39(1):437-441. doi: 10.21873/anticanres.13131.

PMID:
30591492
16.

B-ALL Relapses After Autologous Stem Cell Transplantation Associated With a Shift from e1a2 to e14a2 BCR-ABL Transcripts: A Case Report.

Stella S, Massimino M, Tirrò E, Vitale SR, Scalise L, Leotta S, Pennisi MS, Puma A, Romano C, Stagno F, Sapienza G, Milone G, Manzella L.

Anticancer Res. 2019 Jan;39(1):431-435. doi: 10.21873/anticanres.13130.

PMID:
30591491
17.
18.

L1CAM as a Negative Prognostic Factor in Endometrioid Endometrial Adenocarcinoma FIGO Stage IA-IB.

Klat J, Mladenka A, Dvorackova J, Bajsova S, Simetka O.

Anticancer Res. 2019 Jan;39(1):421-424. doi: 10.21873/anticanres.13128.

PMID:
30591489
19.

Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel KIF5B-ALK Fusion Oncokinase.

Shimizu N, Akashi Y, Fujii T, Shiono H, Yane K, Kitahara T, Ohta Y, Kakudo K, Wakasa T.

Anticancer Res. 2019 Jan;39(1):413-420. doi: 10.21873/anticanres.13127.

PMID:
30591488
20.

Prognostic Significance of Pretreatment Lymphocyte-to-Monocyte Ratio in Patients with Tongue Cancer.

Furukawa K, Kawasaki G, Naruse T, Umeda M.

Anticancer Res. 2019 Jan;39(1):405-412. doi: 10.21873/anticanres.13126.

PMID:
30591487

Supplemental Content

Loading ...
Support Center